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Abstract 
Recent advances in bioengineering and biomaterials, along with knowledge deriving from the fields of 
developmental biology and stem cell research, have rendered feasible functional replacement of full organs. 
Here, we describe the methodology for bioengineering a tooth, starting from embryonic epithelial and 
mesenchymal single cell suspensions. In addition, we describe the subsequent steps of processing this 
minute structure for use in applications such as histological examination, immunofluorescence and in situ 
hybridisation. This methodology can be used for any minute structure that needs to be used in paraffin 
blocks. 
 Detailed methodology for reproducible and reliable results 
 Extra step to ensure single cell populations 
 Subsequent minute structure processing for histological analysis 
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Tissue engineering combines the fields of bioengineering, biomaterials and molecular biology. It aims in 
generating fully functional tissues that can replace damaged organs. Two main strategies, in which cells that 
have the potential to repopulate and regenerate the tissue of interest are used as primary source, are utilized 
in order to produce engineered tissues. First, scaffolds are used in which cells are seeded in vitro. These 
scaffolds can be either synthetic or natural occurring extracellular matrix (decellularized tissues). This 
strategy has been used in a variety of tissues such as liver [1], heart [2], trachea [3], oesophagus [4] and 
skeletal muscle [5] among others.  The second strategy is trying to recapitulate organogenesis in vitro and it 
has been used with great success for the generation of ectodermal organs including teeth [6, 7], hair follicles 
[8], salivary [9] and lacrimal glands [10]. Despite the obvious advantage offered by this strategy in studying 
dental morphogenesis through the plethora of cells of origin (e.g. mouse strains, treated cells, iPS cells), it 
has not been replicated to the degree anticipated. 
 
The tooth is an ectodermal organ that arise from a primordial structure known as tooth germ. During its 
development, epithelial-mesenchymal interactions are of pivotal importance [11]. In mice, the tooth germ 
formation is initiated at embryonic day 10,5 (ED10,5) by signals that arise from the epithelium such as 
FGF8, BMP4, Shh and Eda. These signals result in the expression of an array of transcription factors in the 
dental mesenchyme. Next, the mesenchyme condenses around the developing epithelial bud. At ED14, a 
transient epithelial structure known as the enamel knot appears and functions as the signaling center for 
subsequent tooth morphogenesis [12]. 
 
Materials 
The tooth reconstitution protocol described here is based on the one by Nakao et al. [6] with modifications. 
All experiments involving live animals must conform to national and institutional regulations. In the present 
study, all animal protocols were approved by the Finnish National Board of Animal Experimentation 
(ESAVI/1284/04.10.07/2016). NMRI and Sox2-GFP (kind gift from Fred H. Gage, Salk Institute, CA, USA, 
reference [13]) mice were used and maintained under 12-h light/dark cycle at 22 °C under standard 
conditions. 
 
Tooth bioengineering and organ culture 
For our experiments, we conventionally use incisors from E14,5 mouse embryos. However, we have also 
successful used incisors from E15,5 mouse embryos. 
 
Reagents 
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1. Phosphate-buffered saline (PBS), pH 7.4 (Gibco, cat no. 10010023). 
2. Dulbecco’s modified Eagle’s medium (DMEM), supplemented with GlutaMAXTM (Gibco, cat. no. 
61965026). 
3. Fetal bovine serum (FBS) (HyClone, cat no. SV30160.02). 
4. Penicillin/streptomycin (Gibco, cat no. 15140122). 
5. Ascorbic acid (Sigma, cat no. A4544). 
6. Optimem (Gibco, cat no. 31985070). 
7. Dispase II (Sigma, cat no. D4693). 
8. DNase I (Thermo ScientificTM, cat no. EN0521, final concentration: 20 U/ml). 
9. StemProTM AccutaseTM (Gibco, cat no. A1110501). 
10. Cellmatrix Type I-A (Nitta-Gelatin Inc, cat no. 638-00781). 
 
Reagent set up 
1. Culture medium (serum-containing): DMEM supplemented with GlutaMAXTM, 10% FBS, 1% 
penicillin/streptomycin, 100 μg/ml ascorbic acid. 
2. Culture medium (serum-free): as above, but no FBS. 
3. Dispase II. Dilute to 50 U/ml in a buffer containing 10mM NaAc pH 7.5 and 5mM CaAc. Store at 4 
°C for up to a month. 
4. Prepare Cellmatrix as described in the provider’s protocol, namely:  
a. In 8 volumes of ice-cold Cellmatrix, add 1 volume of 10 x concentrated MEM (without 
NaHCO3) and mix by vortexing. Solution will acquire a light yellow colour. 
b. Add 1 volume of reconstitution and mix by vortexing. The solution will acquire a light pink 
colour. 
Perform steps in a cold 50 ml falcon tube on ice. Prepare Cellmatrix at least 10 min prior to use, or 
after bubbles have disappeared. 
Note: All components are included in the Cellmatrix kit (Cellmatrix Type I-A (Nitta-Gelatin 
Inc, cat no. 638-00781). 
Note: Cellmatrix Type I-A (pH 3) is an acid-soluble Type I collagen derives from porcine 
tendon. Upon reconstitution, it gives a high strength, transparent gel. 
 
Equipment 
1. Glass petri dishes. 
2. Laminar flow hood. 
3. Dissecting stereomicroscope. 
4. Sterilized microdissecting instruments: Scissors, forceps, fine needles. 
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5. Agitator. 
6. Eppendrof tubes. 
7. 35 mm glass cell culture dishes. 
8. Humidified tissue culture incubator (37 °C, 5 % CO2). 
9. Falcon polystyrene round bottom tube with cell-strainer cap (BD). 
10. Siliconized eppendorf tubes. 
11. Cell counter or hemocytometer. 
12. Table top centrifuge. 
13. 50 ml Falcon tubes. 
14. Siliconized dish / surface. 
15. Eppendorf GELoader tips (0.5 – 20 µl) (eppendorf,, cat no 5242956003). 
16. 12-well tissue culture insert (0.4 μm pore dimeter, BD, cat no 353180). 
17. 12-well tissue culture plates. 
 
Histogel embedding and manual tissue processing 
Reagents 
1. 0.5% glutaraldehyde (Sigma, cat no. G7651). 
2. PFA (Sigma, P6148). 
3. Histogel (Thermo ScientificTM, cat no. HG-4000-012). 
4. 50 %, 70 %, 94 % and absolute ethanol. 
5. Xylene. 
6. Wax. 
 
Equipment 
1. Water bath. 
2. Histology mold. 
3. Scalpel. 
4. Histology cassette. 
5. Warm chamber. 
 
Method details 
All procedures – apart from 3.10 and 3.11 – should be carried out in sterile conditions using sterile 
techniques and instruments. All steps are performed at room temperature unless otherwise specified. 
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Tooth bioengineering and organ culture  
 
Tissue dissection 
1. Keep embryos in PBS on ice in glass petri dishes.  
2. Dissect tooth germs (incisors) in PBS using standard procedures (Fig. 1). Extra tissues surrounding the tooth 
germ should be carefully removed.  
3. Store tooth germs in serum-free medium on ice in 35 mm glass cell culture dishes. 
Note: Serum inhibits dispase activity (Epithelial bud and mesenchymal condensate separation). 
 
Epithelial bud and mesenchymal condensate separation 
1. Remove serum-free medium.  
2. Immediately add a solution composed of 960 μl Optimem, 40 μl Dispase II and 4 μl DNase I. Make sure tooth 
germs are submerged into the solution. 
3. Incubate for at least 12.5 min at room temperature. Alternatively, incubate for two hours at 4 °C on an 
agitator.  
4. Separate epithelial buds with the help of a fine needle (Fig. 1). 
Note: The more time, the more efficient the separation. 
 
Epithelial and mesenchymal tissue dissociation 
1. Transfer epithelial buds in siliconized eppendorf tubes that contain 0.6 ml of serum-free medium (Fig. 2).  
2. Do the same for mesenchymal condensates.  
3. Let tissues set at the bottom of the tubes.  
4. Remove supernatant completely.  
5. Add 0.3 ml Accutase in each tube and incubate at 37 °C,  
a. 20 minutes for epithelial buds and  
b. 10 min for mesenchymal condensates.  
6. Add 0.6 ml of serum-containing medium in each tube.  
7. Pipette up and down softly using a 1ml tip, until to see that structures have dissociated into single cells. 
Epithelial buds are more resistant and require more time.  
8. Pass the treated cells through a BD Falcon tube with cell-strainer cap to ensure that all non-single cell 
aggregates are excluded. 
Note: Be careful that only epithelial buds are transferred and no floating mesenchymal cells. 
 
Cell counting and precipitation of single cell suspensions 
1. Pipette single cell suspensions into siliconized eppendorf tubes. 
2. Resuspend cells. 
Jo
urn
l P
re-
pro
of
7 
 
3. Immediately remove a small aliquot from both the epithelial and the mesenchymal single cell suspensions and 
count the number of cells by using a cell counter or a hematocytometer. 
4. Centrifuge single cell suspensions 5 min at 250-300 x g in room temperature. 
5. Remove the supernatant completely without disturbing the pellet. Keep samples on ice. 
Note: Use GELoader tips to ensure that no medium has remained. Remaining liquid and / or 
hampering the cell pellet can result in problems in the injection step.  
 
Bioengineering of germs 
1. Prepare Cellmatrix as described in provider’s protocol and in Section 2.2. Do steps in cold 50 ml falcon tubes 
that are stored on ice. 
2. Let solution to rest on ice for 10 min or until bubbles have disappeared.  
3. Make 30 μl droplets on siliconized dish / siliconized surface (Fig. 3). Proceed immediately to cell injection. 
 
Cell injection in Cellmatrix droplets 
1. Inject 0.2 – 0.3 μl of mesenchymal cells in the center of the Cellmatrix droplet (Fig. 3). Use GELloader tips to 
inject. 
2. Inject 0.1 – 0.2 μl of epithelial cells immediately adjacent to the mesenchymal cell aggregate. Use GELloader 
tips to inject. 
Note: Eppendorf GELloader tips they have a long capillary section. Cut to ~ 3 /4 of the length for 
better manipulation. 
Note: It is important mesenhymal and epithelial cells to be in contact. 
 
Baking of the Cellmatrix droplet 
1. Turn the siliconized dish upside down. 
2. Incubate drops at 37 °C for 10 min. 
 
Transfer of Cellmatrix droplets in cell culture conditions 
Move the Cellmatrix droplet in a 12-well tissue culture insert with the use of forceps. Pay extra attention so the 
droplets not to be ruptured and cell aggregates disperse from the droplet. Place the droplet so at it touches the bottom 
of the cell culture insert and preferably not the walls of the cell culture insert. The round drop will be flattened after 
cultivation, but cells will not move. 
Note: Use 6-well tissue culture inserts (and the corresponding tissue culture plates) for greater 
movement freedom if necessary. 
Note: We tried matrigel instead of Cellmatrix. However, at all matrigel concentrations we used, the 
consistency was not enough to retain the cells in contact. 
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Organ culture 
1. Culture the reconstituted explants for 2 to 14 days on cell culture inserts in 12-well cell culture plates. For 12-
well cell culture plates (22.1 mm well diameter) combined with 0.4 μm pore size inserts (BD, cat no 353180) 
supplement with 300 μl / well serum-containing medium per well, or until medium comes into contact with 
the bottom of the insert (Fig. 3). 
2. Change the serum-containing medium at a 2 day interval. 
 
 
Histogel embedding and manual tissue processing 
 
Histogel encapsulation 
Because of the small size of the reconstituted explants, we suggest that samples are encapsulated in histogel prior to 
paraffin embedding. 
1. Preheat 0.5% glutaraldehyde in 2% PFA (fixative) at 37 °C. 
2. Briefly wash the cell culture insert that contains the reconstituted explants twice with PBS. 
3. Add fixative so as reconstituted explants are embedded in it (put fixative both on top and bottom of the cell 
culture insert). Fix for 4 hours with agitation. 
4. In the meantime, melt the histogel for >45 min at 60-65 °C water bath. 
5. Remove fixative and wash briefly twice with PBS. 
6. Take histology molds and place them on ice.  
7. Add 100 μl   of histogel on top of the sample (on the top surface of the cell culture insert). 
8. Remove the filter from the bottom of the cell culture insert. The reconstituted samples should now be in the 
histogel.  
9. Place reconstituted explants in histology mold. 
10. Cover the reconstituted explants with histogel. Start pipetting from the sides and gradually move towards the 
center to cover the sample. Keep on ice. 
11. Wait for histogel to completely solidify. Remove the histogel encapsulated reconstituted explants by scooping 
it with a scalpel. 
12. Place the histogel encapsulated reconstituted explants in a histology cassette and fix with 4% PFA for 1 hour. 
13. Briefly wash twice with PBS. 
 
Manual tissue processing 
1. Remove the histogel encapsulated reconstituted explants from the histology cassette and put it in a glass vial. 
Submerge the samples as follows in agitation: 
a. 50% ethanol for 4 x 30 min.  
b. 70% ethanol for 4 x 30 min or overnight at 4 °C (change solution to fresh at least four times). 
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c. 94% ethanol for 4 x 30 min. 
d. 100% ethanol for 4 x 30 min.  
e. Xylene for 4 x 30 min.  
2. Remove samples from glass vial and put them on a tissue mold for consequent paraffin embedding. 
3. Put samples in wax for 4 x 30 min (or more) at warm chamber. 
4. Proceed with paraffin embedding. 
Note: Be careful not to remove the reconstituted explants along with the filter. In case this happens, 
use scalpel to carefully remove the reconstituted explants from the filter and put them in the histology 
mold. 
Note: Manual tissue processing is highly recommended as it results in histogel being highly 
transparent at the end of the process and therefore possible to identify the small tissue. 
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Method validation 
Using the above protocol, we were able to grow teeth starting from dissociated epithelial and mesenchymal single cell 
suspensions. Already at day 1, the presumptive teeth primordia are visible (Fig. 4). Culture of only epithelial or 
mesenchymal single cells did not give rise to any identifiable structure (Fig. 4). Immunofluorescence of bioengineered 
teeth shows that cell proliferation is occurring, based on Phospho-Histone3 staining (Fig. 5). At day 10, bioengineered 
teeth have a correct structure, as indicated by hematoxylin/eosin staining (Fig. 6). Development of the bioengineered 
teeth recapitulates in vivo development. Importantly, Sox2, the dental stem cell marker [14, 15] is upregulated at day 4 
(Fig. 7). 
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Figure legends 
Figure 1 
Isolation and separation of mesenchymal condensate and epithelial bud from ED14.5 embryos. Incisors are removed, 
taking special care to remove extra tissues surrounding the tooth germ. Mesenchyme and epithelium are separated by 
enzymatic treatment, followed by mechanical separation. Scale bars, 1000 μm 
 
Figure 1_Stratoulias & Michon 
Figure 2 
Illustration of tissue dissociation and single cell preparation. Epithelial bud and mesenchymal condensate are further 
treated enzymatically to produce single cell suspensions. In order to ensure that single cells are used in following steps 
of the protocols, cell suspensions are filtered through a cell strainer. J
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Figure 2_Stratoulias & Michon 
Figure 3 
Illustration of organ culture preparation. On a siliconized dish, a 30 μl droplet of Cellmatrix is injected with 
mesenchymal cells, followed by epithelial cells. Special care should be taken to inject epithelial cells immediately 
adjacent to the mesenchymal cells. The droplet is transferred on an insert and subsequently cultured. 
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Figure 3_Stratoulias & Michon 
 
Figure 4 
Bioengineered teeth arise from epithelial and mesenchymal single cell suspensions. Mesenchymal or epithelial single 
cell suspensions on their own are not able to generate any recognizable structure. Scale bars, 200 μm. 
 
Figure 4_Stratoulias & Michon 
Figure 5 
Hematoxylin/eosin and immunofluorescence stainings on bioengineered teeth sections. At day 4, cells in the 
bioengineered teeth proliferate, as demonstrated by PhosphoHistone H3 staining (green, ab5176). Tissues were 
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counterstained with Hoechst 33342 (purple). Black scale bars, 200 μm; orange scale bars, 50 μm.
 
Figure 5_Stratoulias & Michon 
Figure 6 
Bioengineered teeth are structurally correct. Hematoxylin/eosin staining of ten-day-old bioengineered teeth. 
Abbreviations: S.I., Stratum Intermediate; Am, Ameloblasts; E.M., Enamel Matrix; D.P. Dental Pulp. Black scale 
bars, 200 μm, orange scale bar, 50 μm. 
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Figure 6_Stratoulias & Michon 
Figure 7 
Bioengineered teeth express SOX2 already at day 4. Mesenchymal and epithelial cells were isolated from Sox2-GFP 
mice. Scale bars, 200 μm. 
 
Figure 7_Stratoulias & Michon 
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SPECIFICATIONS TABLE 
 
Subject Area 
 
• Biochemistry, Genetics and Molecular Biology  
• Medicine and Dentistry  
 
More specific subject area:  
 
Bioengineering 
Method name:  
 
Tooth bioengineering 
Name and reference of original method 
 
K. Nakao, R. Morita, Y. Saji, K. Ishida, Y. Tomita, M. 
Ogawa, M. Saitoh, Y. Tomooka, T. Tsuji, The 
development of a bioengineered organ germ method, 
Nat Methods 4(3) (2007) 227-30 
Resource availability  
 
N/A 
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